Dermata Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $7.9M | $8.2M |
| Jun 2022 | — | $9.7M | $10.6M |
| Sep 2022 | — | $7.5M | $8.1M |
| Dec 2022 | — | $6.0M | $6.2M |
| Mar 2023 | — | $8.1M | $8.8M |
| Jun 2023 | — | $8.0M | $8.4M |
| Sep 2023 | — | $6.4M | $6.6M |
| Dec 2023 | — | $6.4M | $7.4M |
| Mar 2024 | — | $3.8M | $4.7M |
| Jun 2024 | — | $3.3M | $4.9M |
| Sep 2024 | — | $4.7M | $6.1M |
| Dec 2024 | — | $1.6M | $3.2M |
| Mar 2025 | — | $7.3M | $9.7M |
| Jun 2025 | — | $5.6M | $6.5M |
| Sep 2025 | — | $4.0M | $4.7M |
| Dec 2025 | — | $6.2M | $7.5M |
| Mar 2026 | — | $6.4M | $6.9M |
| Jun 2026 | — | $3.5M | $4.4M |